Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | Clinical and Translational Medicine

Fig. 1

From: Combination therapy to checkmate Glioblastoma: clinical challenges and advances

Fig. 1

Schematic representation of combination therapy in treatment of GBM. Targeted therapy approaches have the potential to improve patient outcome in the treatment of Glioblastoma. Small-molecule inhibitors in combination with chemo/radiotherapy can overcome chemo/radioresistance in patients improving treatment efficacy when compared to monotherapy. We summarize small molecule inhibitors and their gene targets that are in preclinical development for GBM therapy and are being tested in combination with radio- and/or chemotherapy

Back to article page